Page last updated: 2024-08-17

levodopa and Multiple System Atrophy Syndrome

levodopa has been researched along with Multiple System Atrophy Syndrome in 100 studies

Research

Studies (100)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	7 (7.00)	18.2507
2000's	53 (53.00)	29.6817
2010's	28 (28.00)	24.3611
2020's	12 (12.00)	2.80

Authors

Authors	Studies
Jiang, W; Li, R; Lin, Y; Ma, L; Zhang, N	1
Comoglu, S; Dinc, E; Kocer, B; Onder, H; Poyraz, U	1
Blaise, AS; Carrière, N; Cuvelier, E; Defebvre, L; Devos, D; Moreau, F; Mutez, E	1
Ahlskog, JE; Ali, F; Botha, H; Carlos, AF; Clark, HM; Coon, EA; Dickson, DW; Josephs, KA; Koga, S; Lowe, V; Pham, NTT; Sekiya, H; Trejo-Lopez, JA; Whitwell, JL	1
Djoukhadar, I; Jabbari, E; Kobylecki, C; Lally, I; Leahy, CB; Morris, HR; Robinson, AC; Roncaroli, F	1
Fanciulli, A; Sidoroff, V; Stankovic, I; Wenning, GK	1
Bhidayasiri, R; Panyakaew, P; Thongchuam, Y	1
Hatano, T; Hattori, N; Kanai, K; Oyama, G; Shimo, Y; Ueno, SI	1
Ishida, C; Kato-Motozaki, Y; Komai, K; Tagami, A; Takahashi, K	1
Chelban, V; Cortese, A; Houlden, H; O'Connor, E; Rossi, S; Sullivan, R; Wood, NW; Yau, WY	1
Cairns, NJ; Criswell, S; Davis, AA; Hartlein, J; Kotzbauer, PT; Maiti, B; Martin, WRW; Miles, M; Norris, SA; Perlmutter, JS; Perrin, RJ; Racette, BA; Ushe, M; Zhong, Q	1
Araki, T; Mukai, T	1
Bassil, F; Bezard, E; Dutheil, N; Fernagut, PO; Guerin, PA; Klugmann, M; Li, Q; Meissner, WG	1
Avenali, M; De Icco, R; Fresia, M; Pacchetti, C; Perrotta, A; Sandrini, G; Serrao, M; Tassorelli, C	1
Brefel-Courbon, C; Galitzsky, M; Gerdelat, A; Harroch, E; Ory-Magne, F; Pavy-Le Traon, A; Pellaprat, J; Rascol, O; Rousseau, V	1
Cheon, SM; Jeong, YJ; Kang, DY; Kim, JW	1
Balint, B; Barbosa, P; Batla, A; Bhatia, KP; Calandra-Buonaura, G; Cortelli, P; De Pablo-Fernandez, E; Erro, R; Holton, JL; Islam, S; Ling, H; Quinn, N; Reich, M; Volkmann, J; Warner, TT	1
Chen, S; Cui, S; Du, JJ; Fu, R; Gao, C; Huang, P; Lin, Y; Wang, T; Zhou, H	1
Alty, J; Currie, S; Khan, S; Sivakumar, G	1
Antonini, A; Berg, D; Coon, E; Cortelli, P; Fanciulli, A; Ferreira, JJ; Freeman, R; Halliday, G; Höglinger, GU; Iodice, V; Kaufmann, H; Kaufmann, LN; Klockgether, T; Kostic, V; Krismer, F; Lang, A; Levin, J; Low, P; Mathias, C; Meissner, WG; Palma, JA; Panicker, JN; Pellecchia, MT; Poewe, W; Quinn, N; Sakakibara, R; Schmahmann, J; Scholz, SW; Seppi, K; Singer, W; Stamelou, M; Stankovic, I; Tolosa, E; Tsuji, S; Vignatelli, L; Wenning, GK	1
Buhmann, C; Jost, WH; Kassubek, J; Lingor, P; Schrag, A; Schwarz, J; Tönges, L	1
Döbrössy, M; Garcia, J; Göbel, G; Granata, R; Jellinger, K; Kaindlstorfer, C; Krismer, F; Stefanova, N; Wenning, GK	1
Greene, P	1
Arakawa, M; Hokari, M; Ishikawa, A; Kondo, T; Mezaki, N; Miura, T; Nishizawa, M; Ozawa, T; Sakai, N; Takeshima, A; Takeuchi, R; Tokunaga, J; Utsumi, K; Yokoseki, A	1
Fukuyama, H; Kawashima, S; Matsukawa, N; Mima, T; Ojika, K; Ueki, Y	1
Ishii, K; Katayama, Y; Nagayama, H; Nakajima, N; Nishiyama, Y; Ueda, M	1
Bergquist, F; Eklund, M; Holmberg, B; Thorlin, T; Zackrisson, T	1
Bolla, M; Paparatti, M; Perrotta, A; Pierelli, F; Sandrini, G; Serrao, M; Tassorelli, C	1
Goulding, N; Kaufmann, H; Martinez, J; Norcliffe-Kaufmann, L; Palma, JA; Roncevic, D	1
Halliday, GM; Lewis, SJ; McCann, H; McGeachie, AB; Silberstein, P	1
Calandra-Buonaura, G; Capellari, S; Contin, M; Cortelli, P; Doria, A; Guaraldi, P; Lopane, G; Martinelli, P	1
Friis, S; Korbo, L; Lassen, CF; Starhof, C; Winge, K	1
Chan, P; Feng, T; Li, W; Lu, L; Shi, W; Wang, Y; Zhang, J	1
Buttarelli, FR; Circella, A; Colosimo, C; Giovannelli, M; Pellicano, C; Pontieri, FE; Tiple, D	1
Aguiar, PM; Barsottini, OG; Borges, V; Felício, AC; Ferraz, HB; Godeiro-Junior, C; Silva, SM	1
Dechant, G; Hainzer, M; Köllensperger, M; Nikkhah, G; Pallua, A; Poewe, W; Puschban, Z; Reindl, M; Stefanova, N; Wenning, GK	1
Cho, J; Hong, YH; Kwon, HM; Nam, H	1
Estévez, S; Merello, M; Perez-Lloret, S	1
Chan, LL; Tan, EK	1
Damon-Perrière, N; Meissner, WG; Tison, F	1
Tison, F	1
Azulay, JP; Balduyck, S; Blin, O; Brefel-Courbon, C; Durif, F; Esquerre, JP; Ory-Magne, F; Payoux, P; Rascol, O; Regragui, W; Thalamas, C; Tison, F	1
Abele, M; Albanese, A; Barone, P; Berciano, J; Boesch, S; Bozi, M; Cardozo, A; Coelho, M; Colosimo, C; Daniels, C; Del Sorbo, F; Deuschl, G; Djaldetti, R; Dupont, E; Fowler, C; Galitzky, M; Gasser, T; Geser, F; Giladi, N; Gonzalez-Mandly, A; Gurevich, T; Kamm, C; Klockgether, T; Köllensperger, M; Mathias, CJ; Meco, G; Ndayisaba, JP; Nilsson, CF; Oertel, W; Ostergaard, K; Pellecchia, MT; Poewe, W; Quinn, N; Rascol, O; Sampaio, C; Schimke, N; Schrag, A; Seppi, K; Siebert, U; Tison, F; Tolosa, E; Wenning, GK; Widner, H; Yekhlef, F	1
Ahlskog, JE; Josephs, KA; Kumar, N; Matsumoto, JY; McKeon, A; Savica, R	1
Goldstein, DS; Holmes, C; Sharabi, Y	1
Ait Benhaddou, EH; Benjelloun, H; Benomar, A; Lachhab, L; Razine, R; Regragui, W; Yahyaoui, M	1
Balestre, E; Chrysostome, V; Poewe, W; Quinn, NP; Tison, F; Wenning, GK; Yekhlef, F	1
Berciano, J; Ferrer, I; Marín, C; Pascual, J; Rey, MJ; Rumià, J; Tolosa, E; Valldeoriola, F	1
Chaudhuri, KR; Landau, S; Winkler, AS	1
Defebvre, L; Degreef, JF; Destee, A; Dujardin, K; Krystkowiak, P	1
Colle, H; Temel, Y; van der Linden, C; Visser-Vandewalle, V	1
Geser, F; Wenning, GK	1
Apetauerova, D; Norregaard, T; Ryan, P; Tarsy, D	1
Hironishi, M; Kondo, T; Miwa, H; Nakanishi, I	1
Geser, F; Stampfer-Kountchev, M; Tison, F; Wenning, GK	1
Bösch, S; Brenneis, C; Büchel, C; Löscher, WN; Luginger, E; Müller, J; Poewe, W; Schocke, MF; Seppi, K; Wenning, GK	1
Baltuch, GH; Chou, KL; Forman, MS; Hurtig, HI; Trojanowski, JQ	1
Benecke, R; Classen, J; Grossmann, A; Kunesch, E; Wolters, A	1
Alcaraz, R; Atarés, B; Bilbao, G; Garibi, J; Gómez-Esteban, JC; Lambarri, I; Lezcano, E; Zarranz, JJ	1
Dostrovsky, JO; Hutchison, WD; Lang, AE; Lozano, AM; Palter, VN; Pereira, LC	1
Andrich, J; Müller, T; Przuntek, H; Saft, C; Stücker, M	1
Cook, R; Garrick, R; Halliday, GM; Huang, Y; Morris, J; O'Sullivan, D	1
Mikolenko, I; Skidmore, F; Weiner, W; Weiss, H	1
Diguet, E; Fernagut, PO; Ghorayeb, I; Tison, F	1
Ahlskog, JE; Bower, JH; Josephs, KA; Klos, KJ; Matsumoto, JY	1
Goldstein, DS	1
Aniel-Quiroga, MA; Barcena, J; Cruz Lachén, M; Gómez, JC; Hurtado, P; Lezcano, E; Pérez Bas, M; Rouco, I; Velasco, F; Zarranz, JJ	1
Esposito, P; Mohr, M; Stilhart, B; Talmant, V; Tranchant, C	1
Diem, A; Högl, B; Peralta, C; Poewe, W; Seppi, K; Wenning, GK	1
Fujiki, N; Sasaki, H; Soma, H; Takei, A; Yabe, I; Yanagihara, T	1
Dragasević, N; Kostić, V; Nesić, N; Pekmezović, T; Ribarić, K; Svetel, M	1
Köllensperger, M; Poewe, W; Reindl, M; Stefanova, N; Wenning, GK	1
Cenci, A; Hainzer, M; Köllensperger, M; Poewe, W; Stefanova, N; Wenning, GK	1
Kim, JS; Lee, KS; Song, IU	1
Pavanni, R; Tan, EK; Tong, J; Wong, MC; Zhao, Y	1
Colcher, A; Gilman, S; Huang, N; Jankovic, J; Lipp, A; Low, PA; Marshall, FJ; May, S; Novak, P; Ondo, WG; Reich, SG; Sandroni, P; Shults, CW; Sowell, BB; Stern, MB; Tanner, CM; Thomas, RG; Wooten, F	1
Bhatia, KP; Cordivari, C; Hanna, MG; Holton, JL; Phadke, R; Quinn, NP; Ryan, AM; van de Warrenburg, BP	1
Hashimoto, M; Inoue, K; Ishii, K; Ishiwata, K; Kawasaki, K; Kimura, Y; Mishina, M; Mitani, K; Murayama, S; Oda, K; Suzuki, M	1
Kaufmann, H	1
Hamamoto, M; Katayama, Y; Mori, O; Nagayama, H; Nishiyama, Y; Ueda, M; Yamazaki, M	1
Quinn, NP; Wenning, GK	1
Damhaut, P; Dethy, S; Goldman, S; Hildebrand, J; Van Blercom, N; Wikler, D	1
Albanese, A; Ben-Shlomo, Y; Fowler, C; Gilman, S; Kaufmann, H; Klockgether, T; Lang, A; Lantos, P; Litvan, I; Low, P; Mathias, C; Oliver, E; Quinn, N; Robertson, D; Schatz, I; Wenning, G	1
Fetoni, V; Girotti, F; Monza, D; Soliveri, P; Testa, D	1
Albanese, A; Ben-Shlomo, Y; Fowler, CJ; Gilman, S; Kaufmann, H; Klockgether, T; Lang, AE; Lantos, PL; Litvan, I; Low, PA; Mathias, CJ; Oliver, E; Quinn, N; Robertson, D; Schatz, I; Wenning, GK	1
Chuda, M; Hayabara, T; Ihara, Y; Kuroda, S	1
Kimber, J; Mathias, CJ; Watson, L	1
Aubert, I; Bezard, E; Fernagut, PO; Ghorayeb, I; Poewe, W; Tison, F; Wenning, GK	1
Bruce, S; Cannon, RO; Goldstein, DS; Holmes, C; Li, ST; Metman, LV	1
Goto, K; Miwa, C; Morita, Y; Shimode, H; Shinjo, H; Ueki, A	1
Abbruzzese, G; Buccolieri, A; Marchese, R; Trompetto, C	1
Lee, MS; Lyoo, CH; Rinne, JO; Syvänen, AC; Ulmanen, I	1
Eriksson, B; Holmberg, B; Ingvarsson, P; Johnels, B; Rosengren, L	1
Factor, SA; Lava, NS	1
Ferrarini, M; Filippini, G; Girotti, F; Monza, D; Soliveri, P; Testa, D	1
Brandauer, E; Högl, B; Poewe, W; Seppi, K; Wenning, G	1
Boesch, SM; Poewe, W; Ransmayr, G; Wenning, GK	1
Mathias, CJ	1
Yokochi, F	1
Balestre, E; Bioulac, B; Chrysostome, V; Ghorayeb, I; Tison, F; Yekhlef, F	1

Reviews

12 review(s) available for levodopa and Multiple System Atrophy Syndrome

Article	Year
A Review on the Clinical Diagnosis of Multiple System Atrophy. Cerebellum (London, England), 2023, Volume: 22, Issue:5 Topics: Adult; Diagnosis, Differential; Humans; Levodopa; Magnetic Resonance Imaging; Multiple System Atrophy; Parkinsonian Disorders	2023
Dyskinesia in multiple system atrophy and progressive supranuclear palsy. Journal of neural transmission (Vienna, Austria : 1996), 2019, Volume: 126, Issue:7 Topics: Diagnosis, Differential; Dyskinesia, Drug-Induced; Dyskinesias; Humans; Levodopa; Multiple System Atrophy; Parkinson Disease; Supranuclear Palsy, Progressive	2019
Progressive Supranuclear Palsy, Corticobasal Degeneration, and Multiple System Atrophy. Continuum (Minneapolis, Minn.), 2019, Volume: 25, Issue:4 Topics: Aged; Basal Ganglia Diseases; Diagnosis, Differential; Dopamine Agents; Female; Humans; Levodopa; Male; Middle Aged; Multiple System Atrophy; Supranuclear Palsy, Progressive	2019
[Multiple system atrophy]. Psychologie & neuropsychiatrie du vieillissement, 2010, Volume: 8, Issue:3 Topics: Aged; Antiparkinson Agents; Atrophy; Brain; Combined Modality Therapy; Cross-Sectional Studies; Humans; Levodopa; Magnetic Resonance Imaging; Multiple System Atrophy; Neurologic Examination; Palliative Care; Parkinsonian Disorders; Physical Therapy Modalities; Prognosis; Survival Rate	2010
["Red flags": when to be alerted and how to explore?]. Revue neurologique, 2010, Volume: 166, Issue:10 Topics: Antiparkinson Agents; Basal Ganglia Diseases; Biomarkers; Diagnosis, Differential; Humans; Levodopa; Lewy Body Disease; Magnetic Resonance Imaging; Multiple System Atrophy; Parkinson Disease; Supranuclear Palsy, Progressive	2010
Multiple system atrophy. Revue neurologique, 2003, Volume: 159, Issue:5 Pt 2 Topics: Antiparkinson Agents; Ataxia; Humans; Hypotension, Orthostatic; Levodopa; Multiple System Atrophy; Nerve Degeneration; Neuroglia; Physical Therapy Modalities; Randomized Controlled Trials as Topic	2003
L-dihydroxyphenylserine (Droxidopa): a new therapy for neurogenic orthostatic hypotension: the US experience. Clinical autonomic research : official journal of the Clinical Autonomic Research Society, 2008, Volume: 18 Suppl 1 Topics: Autonomic Nervous System Diseases; Blood Pressure; Carbidopa; Central Nervous System Diseases; Controlled Clinical Trials as Topic; Droxidopa; Humans; Hypotension, Orthostatic; Levodopa; Multiple System Atrophy; Norepinephrine; United States	2008
Parkinsonism. Multiple system atrophy. Bailliere's clinical neurology, 1997, Volume: 6, Issue:1 Topics: Antiparkinson Agents; Diagnosis, Differential; Diagnostic Imaging; Dopamine Antagonists; Humans; Levodopa; Motor Skills Disorders; Multiple System Atrophy; Neurologic Examination; Psychological Tests; Putamen; Substantia Nigra	1997
Consensus statement on the diagnosis of multiple system atrophy. American Autonomic Society and American Academy of Neurology. Clinical autonomic research : official journal of the Clinical Autonomic Research Society, 1998, Volume: 8, Issue:6 Topics: Antiparkinson Agents; Autonomic Nervous System Diseases; Cerebellar Diseases; Clinical Laboratory Techniques; Humans; Levodopa; Multiple System Atrophy; Parkinson Disease; Pyramidal Tracts; Urinary Tract Physiological Phenomena	1998
Consensus statement on the diagnosis of multiple system atrophy. Journal of the neurological sciences, 1999, Feb-01, Volume: 163, Issue:1 Topics: Autonomic Nervous System Diseases; Cerebellar Ataxia; Diagnosis, Differential; Humans; Levodopa; Multiple System Atrophy; Parkinson Disease; Urination Disorders	1999
Depression in multiple system atrophy: a case report. Psychiatry and clinical neurosciences, 2000, Volume: 54, Issue:4 Topics: Antidepressive Agents; Antiparkinson Agents; Brain; Depression; Female; Humans; Levodopa; Middle Aged; Multiple System Atrophy; Tomography, Emission-Computed, Single-Photon; Urinary Bladder Diseases; Urodynamics	2000
Neurodegeneration, parkinsonian syndromes and autonomic failure. Autonomic neuroscience : basic & clinical, 2002, Feb-28, Volume: 96, Issue:1 Topics: Autonomic Nervous System Diseases; Brain; Cardiovascular Physiological Phenomena; Diagnosis, Differential; Humans; Levodopa; Multiple System Atrophy; Parkinsonian Disorders; Shy-Drager Syndrome; Sympathetic Nervous System	2002

Trials

6 trial(s) available for levodopa and Multiple System Atrophy Syndrome

Article	Year
Executive function differences in multiple system atrophy and Parkinson's disease. Parkinsonism & related disorders, 2003, Volume: 9, Issue:4 Topics: Adult; Age of Onset; Aged; Antiparkinson Agents; Color Perception; Disease Progression; Female; Humans; Levodopa; Male; Memory; Middle Aged; Multiple System Atrophy; Neuropsychological Tests; Parkinson Disease; Psychomotor Performance; Verbal Behavior	2003
[Segmental dysfunction of sweating in multiple system atrophy]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2005, Volume: 56, Issue:8 Topics: Barbiturates; Diagnosis, Differential; Humans; Hypohidrosis; Levodopa; Male; Middle Aged; Multiple System Atrophy	2005
Affective symptoms in multiple system atrophy and Parkinson's disease: response to levodopa therapy. Journal of neurology, neurosurgery, and psychiatry, 1999, Volume: 66, Issue:4 Topics: Antiparkinson Agents; Depression; Humans; Levodopa; Middle Aged; Mood Disorders; Multiple System Atrophy; Parkinson Disease	1999
Genotypes of catechol-O-methyltransferase and response to levodopa treatment in patients with Parkinson's disease. Neuroscience letters, 2001, Feb-02, Volume: 298, Issue:2 Topics: Adult; Aged; Antiparkinson Agents; Catechol O-Methyltransferase; Female; Genotype; Humans; Korea; Levodopa; Male; Middle Aged; Multiple System Atrophy; Parkinson Disease; Polymorphism, Single Nucleotide	2001
CSF-neurofilament and levodopa tests combined with discriminant analysis may contribute to the differential diagnosis of Parkinsonian syndromes. Parkinsonism & related disorders, 2001, Volume: 8, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Algorithms; Antiparkinson Agents; Diagnosis, Differential; Discriminant Analysis; Female; Humans; Levodopa; Male; Middle Aged; Multiple System Atrophy; Nerve Degeneration; Neurofilament Proteins; Parkinsonian Disorders; Spinal Puncture; Supranuclear Palsy, Progressive	2001
Irresistible onset of sleep during acute levodopa challenge in a patient with multiple system atrophy (MSA): placebo-controlled, polysomnographic case report. Movement disorders : official journal of the Movement Disorder Society, 2001, Volume: 16, Issue:6 Topics: Aged; Cross-Over Studies; Disorders of Excessive Somnolence; Dopamine Agents; Double-Blind Method; Humans; Levodopa; Male; Multiple System Atrophy; Polysomnography; Sleep Stages	2001

Other Studies

82 other study(ies) available for levodopa and Multiple System Atrophy Syndrome

Article	Year
Neuroleptic malignant-like syndrome associated multiple system atrophy: report on three cases. BMC neurology, 2022, Feb-25, Volume: 22, Issue:1 Topics: Antipsychotic Agents; Basal Ganglia Diseases; Humans; Levodopa; Multiple System Atrophy; Neuroleptic Malignant Syndrome	2022
Marked response to levodopa in a patient with multiple system atrophy presenting with orthostatic hypotension: should reduced DAT uptake on DaTSCAN be a criterion for response to levodopa? Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2022, Volume: 43, Issue:8 Topics: Autonomic Nervous System Diseases; Blood Pressure; Humans; Hypotension, Orthostatic; Levodopa; Multiple System Atrophy	2022
Use of levodopa-carbidopa intestinal gel to treat patients with multiple system atrophy. Parkinsonism & related disorders, 2022, Volume: 100 Topics: Antiparkinson Agents; Carbidopa; Drug Combinations; Gels; Humans; Levodopa; Multiple System Atrophy; Parkinson Disease; Retrospective Studies	2022
Tau-PET and multimodal imaging in clinically atypical multiple system atrophy masquerading as progressive supranuclear palsy. Parkinsonism & related disorders, 2022, Volume: 101 Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Levodopa; Magnetic Resonance Imaging; Multimodal Imaging; Multiple System Atrophy; Parkinson Disease; Parkinsonian Disorders; Supranuclear Palsy, Progressive	2022
A case of Lewy body disease and anaplastic astrocytoma presenting with atypical parkinsonism. Neuropathology : official journal of the Japanese Society of Neuropathology, 2022, Volume: 42, Issue:6 Topics: Humans; Levodopa; Lewy Body Disease; Multiple System Atrophy; Parkinson Disease; Parkinsonian Disorders	2022
Orofacial dystonia and asssociated bulbar symptoms in multiple system atrophy: A blinded video analysis. Journal of the neurological sciences, 2020, 10-15, Volume: 417 Topics: Dystonia; Dystonic Disorders; Humans; Levodopa; Movement Disorders; Multiple System Atrophy	2020
A Retrospective Imaging Evaluation of Presynaptic Dopaminergic Degeneration in Multiple System Atrophy with Levodopa Induced Dyskinesia. Tremor and other hyperkinetic movements (New York, N.Y.), 2020, 06-15, Volume: 10 Topics: Aged; Dopamine Agents; Dopamine Plasma Membrane Transport Proteins; Dopaminergic Neurons; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Multiple System Atrophy; Neostriatum; Neurodegenerative Diseases; Presynaptic Terminals; Retrospective Studies; Tomography, Emission-Computed, Single-Photon; Tropanes	2020
Effectiveness of Levodopa in Patients with Multiple System Atrophy and Associated Clinicopathological Features. Internal medicine (Tokyo, Japan), 2021, Feb-01, Volume: 60, Issue:3 Topics: Diagnosis, Differential; Humans; Levodopa; Magnetic Resonance Imaging; Multiple System Atrophy; Parkinson Disease; Putamen; Supranuclear Palsy, Progressive	2021
Dopa-Responsive Parkinsonism in a Patient With Homozygous RFC1 Expansions. Movement disorders : official journal of the Movement Disorder Society, 2020, Volume: 35, Issue:10 Topics: Atrophy; Humans; Levodopa; Multiple System Atrophy; Parkinsonian Disorders	2020
Is Levodopa Response a Valid Indicator of Parkinson's Disease? Movement disorders : official journal of the Movement Disorder Society, 2021, Volume: 36, Issue:4 Topics: Humans; Levodopa; Multiple System Atrophy; Parkinson Disease; Parkinsonian Disorders; Supranuclear Palsy, Progressive	2021
Treatment of Painless Legs and Moving Toes Syndrome Associated With Multiple System Atrophy With Levodopa. Neurology, 2021, 08-31, Volume: 97, Issue:9 Topics: Dopamine Agents; Female; Humans; Levodopa; Middle Aged; Movement Disorders; Multiple System Atrophy; Syndrome	2021
Viral-mediated oligodendroglial alpha-synuclein expression models multiple system atrophy. Movement disorders : official journal of the Movement Disorder Society, 2017, Volume: 32, Issue:8 Topics: alpha-Synuclein; Animals; Animals, Genetically Modified; Corpus Striatum; Dependovirus; Disease Models, Animal; Dopamine Agents; Gene Expression Regulation; Haplorhini; Humans; Levodopa; Male; Multiple System Atrophy; Myelin Basic Protein; Nerve Tissue Proteins; Oligodendroglia; Phosphorylation; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Substantia Nigra	2017
Pain processing in atypical Parkinsonisms and Parkinson disease: A comparative neurophysiological study. Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology, 2017, Volume: 128, Issue:10 Topics: Aged; Female; Humans; Levodopa; Male; Middle Aged; Multiple System Atrophy; Pain; Pain Measurement; Parkinson Disease; Parkinsonian Disorders; Supranuclear Palsy, Progressive	2017
Abnormal pain perception in patients with Multiple System Atrophy. Parkinsonism & related disorders, 2018, Volume: 48 Topics: Aged; Dopamine Agents; Female; Humans; Levodopa; Male; Middle Aged; Multiple System Atrophy; Pain; Pain Measurement; Pain Perception; Pain Threshold; Parkinson Disease; Physical Stimulation; Psychiatric Status Rating Scales; Psychological Tests	2018
F-18 FP-CIT PET in Multiple System Atrophy of the Cerebellar Type: Additional Role in Treatment. Contrast media & molecular imaging, 2017, Volume: 2017 Topics: Aged; Cerebellar Ataxia; Dopamine Plasma Membrane Transport Proteins; Female; Humans; Levodopa; Male; Middle Aged; Multiple System Atrophy; Positron-Emission Tomography; Tropanes	2017
Young-onset multiple system atrophy: Clinical and pathological features. Movement disorders : official journal of the Movement Disorder Society, 2018, Volume: 33, Issue:7 Topics: Adult; Age of Onset; Cohort Studies; Dopamine Agents; Female; Genetic Testing; Humans; Levodopa; Male; Middle Aged; Multiple System Atrophy	2018
Clinical characteristics and quality of life in Chinese patients with multiple system atrophy. Brain and behavior, 2018, Volume: 8, Issue:12 Topics: Antiparkinson Agents; Anxiety Disorders; Asian People; China; Cognitive Dysfunction; Depressive Disorder; Female; Humans; Levodopa; Male; Middle Aged; Multiple System Atrophy; Parkinson Disease; Quality of Life	2018
Multiple system atrophy mimicked by multi-organ pathology. Practical neurology, 2019, Volume: 19, Issue:4 Topics: Aged; Diagnosis, Differential; Humans; Levodopa; Male; Multiple Organ Failure; Multiple System Atrophy; Parkinsonian Disorders	2019
A critique of the second consensus criteria for multiple system atrophy. Movement disorders : official journal of the Movement Disorder Society, 2019, Volume: 34, Issue:7 Topics: Consensus; Genetic Predisposition to Disease; Humans; Levodopa; Multiple System Atrophy; Treatment Outcome	2019
L-dopa response pattern in a rat model of mild striatonigral degeneration. PloS one, 2019, Volume: 14, Issue:6 Topics: Animals; Behavior, Animal; Corpus Striatum; Denervation; Disease Models, Animal; Levodopa; Motor Activity; Multiple System Atrophy; Quinolinic Acid; Rats; Striatonigral Degeneration	2019
Abnormal ghrelin secretion contributes to gastrointestinal symptoms in multiple system atrophy patients. Journal of neurology, 2013, Volume: 260, Issue:8 Topics: Aged; Antiparkinson Agents; Autonomic Nervous System Diseases; Female; Gastrointestinal Diseases; Ghrelin; Hormones; Humans; Levodopa; Male; Multiple System Atrophy	2013
Differences in dopaminergic modulation to motor cortical plasticity between Parkinson's disease and multiple system atrophy. PloS one, 2013, Volume: 8, Issue:5 Topics: Adult; Aged; Antiparkinson Agents; Electric Stimulation; Electromyography; Evoked Potentials, Motor; Female; Humans; Levodopa; Male; Median Nerve; Middle Aged; Motor Cortex; Multiple System Atrophy; Neuronal Plasticity; Parkinson Disease; Transcranial Magnetic Stimulation; Wrist	2013
Therapeutic response to pramipexole in a patient with multiple system atrophy with predominant parkinsonism: positron emission tomography and pharmacokinetic assessments. Internal medicine (Tokyo, Japan), 2013, Volume: 52, Issue:15 Topics: Antiparkinson Agents; Benzothiazoles; Brain; Comorbidity; Dose-Response Relationship, Drug; Humans; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Multiple System Atrophy; Parkinsonian Disorders; Positron-Emission Tomography; Pramipexole; Treatment Outcome	2013
The discriminating properties of an optoelectronic movement analysis method in patients with parkinsonism. Journal of motor behavior, 2013, Volume: 45, Issue:5 Topics: Aged; Antiparkinson Agents; Diagnosis, Differential; Female; Humans; Levodopa; Linear Models; Logistic Models; Male; Middle Aged; Movement; Multiple System Atrophy; Parkinsonian Disorders; Posture; Reproducibility of Results; ROC Curve; Supranuclear Palsy, Progressive	2013
Enhanced temporal pain processing in multiple system atrophy. Neuroscience letters, 2013, Oct-25, Volume: 555 Topics: Aged; Antiparkinson Agents; Case-Control Studies; Female; Humans; Levodopa; Lower Extremity; Male; Middle Aged; Multiple System Atrophy; Pain; Pain Measurement; Pain Threshold; Parkinson Disease; Psychophysics; Reflex	2013
Cerebellar and parkinsonian phenotypes in multiple system atrophy: similarities, differences and survival. Journal of neural transmission (Vienna, Austria : 1996), 2014, Volume: 121, Issue:5 Topics: Age of Onset; Anti-Dyskinesia Agents; Brain; Disease Progression; Female; Humans; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Motor Activity; Multiple System Atrophy; Phenotype; Prevalence; Prognosis; Retrospective Studies; Sex Factors; Survival Analysis; Treatment Outcome	2014
Restricted disease propagation in multiple system atrophy with prolonged survival. Neuropathology and applied neurobiology, 2015, Volume: 41, Issue:5 Topics: Aged, 80 and over; Brain; Disease Progression; Fatal Outcome; Female; Humans; Levodopa; Multiple System Atrophy	2015
Pharmacodynamics of a low subacute levodopa dose helps distinguish between multiple system atrophy with predominant Parkinsonism and Parkinson's disease. Journal of neurology, 2016, Volume: 263, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Benserazide; Diagnosis, Differential; Dopamine Agents; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Motor Activity; Multiple System Atrophy; Parkinson Disease; Retrospective Studies	2016
Clinical Features in a Danish Population-Based Cohort of Probable Multiple System Atrophy Patients. Neuroepidemiology, 2016, Volume: 46, Issue:4 Topics: Adult; Age of Onset; Aged; Cohort Studies; Denmark; Female; Humans; Kaplan-Meier Estimate; Levodopa; Male; Middle Aged; Multiple System Atrophy; Treatment Outcome	2016
Acute stepwise challenge test with levodopa in treated patients with parkinsonism. Parkinsonism & related disorders, 2009, Volume: 15, Issue:5 Topics: Age of Onset; Aged; Antiparkinson Agents; Benserazide; Cohort Studies; Deep Brain Stimulation; Demography; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Multiple System Atrophy; Parkinson Disease; Predictive Value of Tests; Prospective Studies; ROC Curve; Treatment Outcome	2009
Dopamine transporter immunoreactivity in peripheral blood lymphocytes in multiple system atrophy. Journal of neural transmission (Vienna, Austria : 1996), 2009, Volume: 116, Issue:2 Topics: Aged; Dopamine Agents; Dopamine Plasma Membrane Transport Proteins; Female; Humans; Immunohistochemistry; Levodopa; Lymphocytes; Male; Middle Aged; Multiple System Atrophy	2009
Clinical features of dystonia in atypical parkinsonism. Arquivos de neuro-psiquiatria, 2008, Volume: 66, Issue:4 Topics: Adult; Aged; Antiparkinson Agents; Cerebral Cortex; Dystonia; Female; Humans; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Multiple System Atrophy; Nerve Degeneration; Parkinsonian Disorders; Supranuclear Palsy, Progressive	2008
Striatal transplantation in a rodent model of multiple system atrophy: effects on L-Dopa response. Journal of neuroscience research, 2009, May-15, Volume: 87, Issue:7 Topics: Analysis of Variance; Animals; Apomorphine; Brain; Corpus Striatum; Disease Models, Animal; Dopamine Agents; Levodopa; Male; Motor Activity; Multiple System Atrophy; Random Allocation; Rats; Rats, Wistar; Transplantation, Homologous	2009
Does multiple system atrophy itself affect sleep structure? The neurologist, 2009, Volume: 15, Issue:5 Topics: Dopamine Agents; Female; Humans; Levodopa; Male; Middle Aged; Multiple System Atrophy; Polysomnography; Sleep; Sleep Stages; Time Factors; Wakefulness	2009
Does clinical intolerance to a diagnostic acute levodopa challenge differentiate multiple system atrophy from PD? The International journal of neuroscience, 2009, Volume: 119, Issue:12 Topics: Diagnosis, Differential; Dopamine Agents; Female; Follow-Up Studies; Humans; Levodopa; Male; Multiple System Atrophy; Parkinson Disease; Sensitivity and Specificity	2009
'Diphasic' levodopa-induced chorea in multiple system atrophy. International journal of clinical practice, 2010, Volume: 64, Issue:1 Topics: Chorea; Dopamine Agents; Humans; Levodopa; Male; Middle Aged; Multiple System Atrophy	2010
Motor activation in multiple system atrophy and Parkinson disease: a PET study. Neurology, 2010, Sep-28, Volume: 75, Issue:13 Topics: Aged; Brain Mapping; Case-Control Studies; Deuterium Oxide; Dopamine Agents; Functional Laterality; Hand; Humans; Levodopa; Motor Cortex; Movement; Multiple System Atrophy; Parkinson Disease; Positron-Emission Tomography; Statistics, Nonparametric	2010
Presentation, diagnosis, and management of multiple system atrophy in Europe: final analysis of the European multiple system atrophy registry. Movement disorders : official journal of the Movement Disorder Society, 2010, Nov-15, Volume: 25, Issue:15 Topics: Age of Onset; Antiparkinson Agents; Cerebellar Ataxia; Europe; Female; Humans; Hypotension, Orthostatic; Levodopa; Male; Middle Aged; Multiple System Atrophy; Parkinsonian Disorders; Registries; Shy-Drager Syndrome	2010
Parkinsonism and dropped head: dystonia, myopathy or both? Parkinsonism & related disorders, 2012, Volume: 18, Issue:1 Topics: Aged; Carbidopa; Drug Combinations; Dystonic Disorders; Electromyography; Female; Head Movements; Humans; Levodopa; Male; Middle Aged; Multiple System Atrophy; Muscular Diseases; Parkinsonian Disorders; Retrospective Studies	2012
Cerebrospinal fluid biomarkers of central catecholamine deficiency in Parkinson's disease and other synucleinopathies. Brain : a journal of neurology, 2012, Volume: 135, Issue:Pt 6 Topics: 3,4-Dihydroxyphenylacetic Acid; Aged; Biomarkers; Catecholamines; Dopamine Agents; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Levodopa; Male; Methoxyhydroxyphenylglycol; Middle Aged; Multiple System Atrophy; Parkinsonian Disorders; Positron-Emission Tomography; Pure Autonomic Failure; ROC Curve	2012
Profile of multiple system atrophy in Moroccan patients attending a movement disorders outpatient clinic in Rabat university hospital. Revue neurologique, 2013, Volume: 169, Issue:2 Topics: Adult; Age of Onset; Aged; Aged, 80 and over; Amantadine; Disease Progression; Dopamine Agonists; Female; Hospitals, University; Humans; Hypotension, Orthostatic; Levodopa; Magnetic Resonance Imaging; Male; Mental Disorders; Middle Aged; Morocco; Movement Disorders; Multiple System Atrophy; Outpatient Clinics, Hospital; Phenotype; Retrospective Studies; Sleep Disorders, Intrinsic; Symptom Assessment; Urination Disorders	2013
Parkinsonism in multiple system atrophy: natural history, severity (UPDRS-III), and disability assessment compared with Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2002, Volume: 17, Issue:4 Topics: Activities of Daily Living; Aged; Antiparkinson Agents; Disability Evaluation; Female; Humans; Levodopa; Male; Mental Status Schedule; Middle Aged; Multiple System Atrophy; Neurologic Examination; Parkinsonian Disorders; Reproducibility of Results	2002
Presynaptic parkinsonism in multiple system atrophy mimicking Parkinson's disease: a clinicopathological case study. Movement disorders : official journal of the Movement Disorder Society, 2002, Volume: 17, Issue:4 Topics: Brain; Combined Modality Therapy; Diagnosis, Differential; Electric Stimulation Therapy; Electrodes, Implanted; Humans; Levodopa; Male; Middle Aged; Multiple System Atrophy; Neurologic Examination; Parkinson Disease; Parkinsonian Disorders; Receptors, Presynaptic; Subthalamic Nucleus	2002
Serum prolactin levels in Parkinson's disease and multiple system atrophy. Clinical autonomic research : official journal of the Clinical Autonomic Research Society, 2002, Volume: 12, Issue:5 Topics: Aged; Diagnosis, Differential; Dopamine Agents; Female; Head-Down Tilt; Humans; Levodopa; Male; Middle Aged; Multiple System Atrophy; Parkinson Disease; Prolactin	2002
Bilateral high-frequency stimulation of the subthalamic nucleus in patients with multiple system atrophy--parkinsonism. Report of four cases. Journal of neurosurgery, 2003, Volume: 98, Issue:4 Topics: Activities of Daily Living; Aged; Antiparkinson Agents; Benzamides; Combined Modality Therapy; Contrast Media; Electric Stimulation Therapy; Female; Follow-Up Studies; Functional Laterality; Humans; Levodopa; Male; Middle Aged; Multiple System Atrophy; Parkinson Disease; Pyrrolidines; Subthalamic Nucleus; Tomography, Emission-Computed, Single-Photon; Treatment Outcome	2003
Adverse effects of subthalamic nucleus DBS in a patient with multiple system atrophy. Neurology, 2003, Jul-22, Volume: 61, Issue:2 Topics: Antiparkinson Agents; Atrophy; Carbidopa; Combined Modality Therapy; Contraindications; Deglutition Disorders; Diagnosis, Differential; Dysarthria; Electric Stimulation Therapy; Electrodes, Implanted; Female; Humans; Levodopa; Magnetic Resonance Imaging; Microelectrodes; Middle Aged; Multiple System Atrophy; Parkinson Disease; Pons; Putamen; Subthalamic Nucleus	2003
[A patient with multiple system atrophy presenting prolonged levodopa-responsive parkinsonism and off-dystonia of the trunk]. No to shinkei = Brain and nerve, 2003, Volume: 55, Issue:7 Topics: Brain; Diagnosis, Differential; Dystonia; Humans; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Multiple System Atrophy; Olivopontocerebellar Atrophies; Parkinsonian Disorders; Time Factors	2003
Multiple system atrophy: an update. Movement disorders : official journal of the Movement Disorder Society, 2003, Volume: 18 Suppl 6 Topics: alpha-Synuclein; Animals; Brain; Clinical Trials as Topic; Humans; Inclusion Bodies; Levodopa; Multiple System Atrophy; Nerve Tissue Proteins; Neurologic Examination; Neurons; Neuroprotective Agents; Parkinsonian Disorders; Synucleins	2003
Voxel-based morphometry detects cortical atrophy in the Parkinson variant of multiple system atrophy. Movement disorders : official journal of the Movement Disorder Society, 2003, Volume: 18, Issue:10 Topics: Aged; Antiparkinson Agents; Brain Mapping; Case-Control Studies; Demography; Functional Laterality; Humans; Levodopa; Magnetic Resonance Imaging; Middle Aged; Multiple System Atrophy; Parkinsonian Disorders	2003
Subthalamic nucleus deep brain stimulation in a patient with levodopa-responsive multiple system atrophy. Case report. Journal of neurosurgery, 2004, Volume: 100, Issue:3 Topics: Antiparkinson Agents; Basal Ganglia; Brain Stem; Cerebellum; Diagnosis, Differential; Electric Stimulation Therapy; Fatal Outcome; Humans; Levodopa; Male; Middle Aged; Multiple System Atrophy; Parkinson Disease; Substantia Nigra; Subthalamic Nucleus	2004
Measurements of transcallosally mediated cortical inhibition for differentiating parkinsonian syndromes. Movement disorders : official journal of the Movement Disorder Society, 2004, Volume: 19, Issue:5 Topics: Aged; Antiparkinson Agents; Basal Ganglia Diseases; Corpus Callosum; Diagnosis, Differential; Electromyography; Humans; Levodopa; Magnetic Resonance Imaging; Magnetoencephalography; Middle Aged; Motor Cortex; Multiple System Atrophy; Muscle, Skeletal; Nerve Degeneration; Nerve Net; Neural Inhibition; Parkinsonian Disorders; Supranuclear Palsy, Progressive	2004
Parkinson's disease-like presentation of multiple system atrophy with poor response to STN stimulation: a clinicopathological case report. Movement disorders : official journal of the Movement Disorder Society, 2004, Volume: 19, Issue:8 Topics: Antiparkinson Agents; Benzamides; Dopamine Antagonists; Electric Stimulation Therapy; Follow-Up Studies; Humans; Immunohistochemistry; Levodopa; Male; Middle Aged; Multiple System Atrophy; Nerve Tissue Proteins; Neurons; Parkinson Disease; Pyrrolidines; Retrospective Studies; Staining and Labeling; Subthalamic Nucleus; Synucleins; Tomography, Emission-Computed, Single-Photon	2004
Neuronal activity in the globus pallidus of multiple system atrophy patients. Movement disorders : official journal of the Movement Disorder Society, 2004, Volume: 19, Issue:12 Topics: Adult; Aged; Anticonvulsants; Antiparkinson Agents; Female; Globus Pallidus; Humans; Levodopa; Male; Microelectrodes; Middle Aged; Multiple System Atrophy; Neurosurgical Procedures; Parkinson Disease	2004
Pallidal stimulation reduces treatment-induced dyskinesias in "minimal-change" multiple system atrophy. Movement disorders : official journal of the Movement Disorder Society, 2005, Volume: 20, Issue:8 Topics: Deep Brain Stimulation; Dyskinesia, Drug-Induced; Female; Functional Laterality; Globus Pallidus; Humans; Immunohistochemistry; Levodopa; Magnetic Resonance Imaging; Middle Aged; Multiple System Atrophy; Nerve Tissue Proteins; Neuropsychological Tests; Staining and Labeling; Synucleins; Ubiquitin	2005
Camptocormia in a patient with multiple system atrophy. Movement disorders : official journal of the Movement Disorder Society, 2005, Volume: 20, Issue:8 Topics: Antiparkinson Agents; Cerebellum; Disease Progression; Humans; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Movement Disorders; Multiple System Atrophy; Nerve Tissue Proteins; Oligodendroglia; Posture; Spinal Diseases; Synucleins	2005
In vivo models of multiple system atrophy. Movement disorders : official journal of the Movement Disorder Society, 2005, Volume: 20 Suppl 12 Topics: alpha-Synuclein; Animals; Antiparkinson Agents; Corpus Striatum; Levodopa; Macaca fascicularis; Mice; MPTP Poisoning; Multiple System Atrophy; Oxidopamine; Parkinsonian Disorders; Point Mutation; Rats; Substantia Nigra	2005
Pathological hypersexuality predominantly linked to adjuvant dopamine agonist therapy in Parkinson's disease and multiple system atrophy. Parkinsonism & related disorders, 2005, Volume: 11, Issue:6 Topics: Adult; Aged; Antiparkinson Agents; Benzothiazoles; Catechols; Databases, Factual; Dopamine Agonists; Humans; Indoles; Levodopa; Male; Mental Disorders; Middle Aged; Multiple System Atrophy; Nitriles; Parkinson Disease; Pramipexole; Sexual Dysfunctions, Psychological; Thiazoles	2005
Orthostatic hypotension as an early finding in Parkinson's disease. Clinical autonomic research : official journal of the Clinical Autonomic Research Society, 2006, Volume: 16, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Autonomic Nervous System; Diagnosis, Differential; Female; Humans; Hypotension, Orthostatic; Levodopa; Male; Middle Aged; Movement Disorders; Multiple System Atrophy; Parkinson Disease; Time Factors	2006
[Utility of the study of the vegetative nervous system in the differential diagnosis between Parkinson's disease and multiple system atrophy]. Neurologia (Barcelona, Spain), 2006, Volume: 21, Issue:3 Topics: Aged; Antiparkinson Agents; Apomorphine; Autonomic Nervous System; Autonomic Nervous System Diseases; Diagnosis, Differential; Female; Humans; Levodopa; Male; Middle Aged; Multiple System Atrophy; Norepinephrine; Parkinson Disease	2006
[Subthalamic stimulation in a patient with multiple system atrophy: a clinicopathological report]. Revue neurologique, 2006, Volume: 162, Issue:3 Topics: Adenoma; alpha-Synuclein; Antiparkinson Agents; Biomarkers; Brain; Brain Chemistry; Combined Modality Therapy; Deep Brain Stimulation; Diagnostic Errors; Disease Progression; Fatal Outcome; Humans; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Multiple System Atrophy; Parkinson Disease; Prostatectomy; Prostatic Neoplasms; Substantia Nigra; Subthalamic Nucleus; Ubiquitin	2006
Levodopa-induced sleepiness in the Parkinson variant of multiple system atrophy. Movement disorders : official journal of the Movement Disorder Society, 2006, Volume: 21, Issue:8 Topics: Aged; Disorders of Excessive Somnolence; Dopamine Agents; Humans; Levodopa; Middle Aged; Multiple System Atrophy; Parkinson Disease	2006
MSA-C is the predominant clinical phenotype of MSA in Japan: analysis of 142 patients with probable MSA. Journal of the neurological sciences, 2006, Nov-15, Volume: 249, Issue:2 Topics: Adult; Aged; Antiparkinson Agents; Autonomic Nervous System; Cerebellar Ataxia; Death, Sudden; Diagnostic Imaging; Drug Resistance; Female; Follow-Up Studies; Humans; Japan; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Movement Disorders; Multiple System Atrophy; Parkinsonian Disorders; Phenotype; Retrospective Studies; Vocal Cord Paralysis	2006
[Clinical characteristics of multiple system atrophy in serbian population]. Vojnosanitetski pregled, 2006, Volume: 63, Issue:10 Topics: Antiparkinson Agents; Female; Humans; Levodopa; Male; Middle Aged; Multiple System Atrophy	2006
Loss of dopaminergic responsiveness in a double lesion rat model of the Parkinson variant of multiple system atrophy. Movement disorders : official journal of the Movement Disorder Society, 2007, Feb-15, Volume: 22, Issue:3 Topics: Analysis of Variance; Animals; Apomorphine; Behavior, Animal; Disease Models, Animal; Functional Laterality; Levodopa; Male; Multiple System Atrophy; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Wistar; Substantia Nigra	2007
High dose levodopa therapy is not toxic in multiple system atrophy: experimental evidence. Movement disorders : official journal of the Movement Disorder Society, 2007, May-15, Volume: 22, Issue:7 Topics: alpha-Synuclein; Analysis of Variance; Animal Diseases; Animals; Antiparkinson Agents; Corpus Striatum; Dose-Response Relationship, Drug; Levodopa; Mice; Mice, Inbred C57BL; Mice, Transgenic; Motor Activity; Multiple System Atrophy; Nerve Tissue Proteins	2007
Dopa-responsive camptocormia in a patient with multiple system atrophy. Parkinsonism & related disorders, 2008, Volume: 14, Issue:2 Topics: 3-Iodobenzylguanidine; Antiparkinson Agents; Female; Heart; Humans; Levodopa; Middle Aged; Movement; Movement Disorders; Multiple System Atrophy; Parkinson Disease; Posture; Radionuclide Imaging; Radiopharmaceuticals	2008
Genetic analysis of SCA 2 and 3 repeat expansions in essential tremor and atypical Parkinsonism. Movement disorders : official journal of the Movement Disorder Society, 2007, Oct-15, Volume: 22, Issue:13 Topics: Adult; Antiparkinson Agents; Ataxin-3; Ataxins; Cross-Sectional Studies; Diagnosis, Differential; DNA Mutational Analysis; Drug Resistance; Essential Tremor; Female; Genetic Testing; Genotype; Humans; Levodopa; Male; Middle Aged; Motor Skills Disorders; Multiple System Atrophy; Nerve Tissue Proteins; Neurologic Examination; Nuclear Proteins; Parkinsonian Disorders; Phenotype; Polymerase Chain Reaction; Repressor Proteins; Spinocerebellar Ataxias; Supranuclear Palsy, Progressive; Trinucleotide Repeat Expansion; Trinucleotide Repeats	2007
Potential outcome measures and trial design issues for multiple system atrophy. Movement disorders : official journal of the Movement Disorder Society, 2007, Volume: 22, Issue:16 Topics: Aged; Antiparkinson Agents; Cerebellar Diseases; Clinical Trials as Topic; Disability Evaluation; Disease Progression; Female; Humans; Levodopa; Male; Middle Aged; Multiple System Atrophy; Research Design; Risk Factors; Sample Size; Socioeconomic Factors; Treatment Outcome	2007
The phenomenon of disproportionate antecollis in Parkinson's disease and multiple system atrophy. Movement disorders : official journal of the Movement Disorder Society, 2007, Volume: 22, Issue:16 Topics: Aged; Antiparkinson Agents; Botulinum Toxins, Type A; Electromyography; Electrophysiology; Female; Fibrosis; Head; Humans; Levodopa; Male; Middle Aged; Movement; Multiple System Atrophy; Muscle, Skeletal; Neck; Neuromuscular Agents; Parkinson Disease	2007
Presynaptic and postsynaptic nigrostriatal dopaminergic functions in multiple system atrophy. Neuroreport, 2008, Jan-22, Volume: 19, Issue:2 Topics: Aged; Biomarkers; Corpus Striatum; Dendrites; Dopamine; Dopamine Plasma Membrane Transport Proteins; Female; Humans; Levodopa; Male; Middle Aged; Multiple System Atrophy; Neural Pathways; Positron-Emission Tomography; Predictive Value of Tests; Presynaptic Terminals; Receptors, Dopamine D2; Substantia Nigra; Synapses; Synaptic Transmission	2008
Low myocardial MIBG uptake in multiple system atrophy with incidental Lewy body pathology: an autopsy case report. Movement disorders : official journal of the Movement Disorder Society, 2008, May-15, Volume: 23, Issue:7 Topics: 3-Iodobenzylguanidine; Aged; Antiparkinson Agents; Fatal Outcome; Humans; Levodopa; Lewy Body Disease; Male; Multiple System Atrophy; Myocardium; Radiopharmaceuticals	2008
Asymmetry of basal ganglia glucose metabolism and dopa responsiveness in parkinsonism. Movement disorders : official journal of the Movement Disorder Society, 1998, Volume: 13, Issue:2 Topics: Adult; Aged; Antiparkinson Agents; Basal Ganglia; Blood Glucose; Brain Mapping; Dominance, Cerebral; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Levodopa; Male; Middle Aged; Motor Skills; Multiple System Atrophy; Neurologic Examination; Parkinson Disease; Tomography, Emission-Computed; Treatment Outcome	1998
Hydroxyl radical and superoxide dismutase in blood of patients with Parkinson's disease: relationship to clinical data. Journal of the neurological sciences, 1999, Nov-30, Volume: 170, Issue:2 Topics: Age Factors; Age of Onset; Aged; Antiparkinson Agents; Bromocriptine; Disease Progression; Erythrocytes; Humans; Hydroxyl Radical; Levodopa; Middle Aged; Multiple System Atrophy; Parkinson Disease; Pergolide; Severity of Illness Index; Statistics as Topic; Superoxide Dismutase; Time Factors	1999
Neuroendocrine responses to levodopa in multiple system atrophy (MSA). Movement disorders : official journal of the Movement Disorder Society, 1999, Volume: 14, Issue:6 Topics: Adult; Aged; Antiparkinson Agents; Blood Glucose; Carbidopa; Dopamine; Drug Combinations; Female; Growth Hormone-Releasing Hormone; Human Growth Hormone; Humans; Hypothalamo-Hypophyseal System; Insulin-Like Growth Factor I; Levodopa; Male; Middle Aged; Multiple System Atrophy; Reference Values; Thyrotropin	1999
Toward a primate model of L-dopa-unresponsive parkinsonism mimicking striatonigral degeneration. Movement disorders : official journal of the Movement Disorder Society, 2000, Volume: 15, Issue:3 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; Brain Mapping; Corpus Striatum; Diagnosis, Differential; Disease Models, Animal; Dopamine; Levodopa; Macaca fascicularis; Male; Multiple System Atrophy; Nerve Degeneration; Neurotoxins; Nitro Compounds; Parkinson Disease, Secondary; Propionates; Striatonigral Degeneration	2000
Cardiac sympathetic denervation in Parkinson disease. Annals of internal medicine, 2000, Sep-05, Volume: 133, Issue:5 Topics: Adult; Aged; Blood Pressure; Brain; Cardiac Catheterization; Diagnosis, Differential; Dopamine; Female; Fluorine Radioisotopes; Heart; Heart Rate; Humans; Levodopa; Male; Methoxyhydroxyphenylglycol; Middle Aged; Multiple System Atrophy; Myocardium; Norepinephrine; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals; Sympathetic Nervous System; Tritium; Valsalva Maneuver	2000
Abnormalities of motor cortical excitability are not correlated with clinical features in atypical parkinsonism. Movement disorders : official journal of the Movement Disorder Society, 2000, Volume: 15, Issue:6 Topics: Adult; Aged; Antiparkinson Agents; Basal Ganglia Cerebrovascular Disease; Case-Control Studies; Electromyography; Evoked Potentials, Motor; Female; Humans; Levodopa; Magnetics; Magnetoencephalography; Male; Middle Aged; Motor Cortex; Multiple System Atrophy; Parkinsonian Disorders; Statistics, Nonparametric	2000
Focal myopathy as a cause of anterocollis in Parkinsonism. Movement disorders : official journal of the Movement Disorder Society, 2001, Volume: 16, Issue:4 Topics: Aged; Biopsy; Diagnosis, Differential; Dystonic Disorders; Female; Humans; Levodopa; Multiple System Atrophy; Neck Muscles; Neurologic Examination; Parkinson Disease	2001
Comparison of natural histories of progressive supranuclear palsy and multiple system atrophy. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2001, Volume: 22, Issue:3 Topics: Aged; Antiparkinson Agents; Disability Evaluation; Disease Progression; Female; Humans; Levodopa; Life Tables; Male; Middle Aged; Multiple System Atrophy; Supranuclear Palsy, Progressive	2001
Dystonia in multiple system atrophy. Journal of neurology, neurosurgery, and psychiatry, 2002, Volume: 72, Issue:3 Topics: Aged; Brain; Dyskinesia, Drug-Induced; Dystonia; Female; Humans; Levodopa; Male; Middle Aged; Multiple System Atrophy; Neurologic Examination; Parkinson Disease, Secondary	2002
[Multiple system atrophy which had been treated as juvenile Parkinson's disease]. No to shinkei = Brain and nerve, 2002, Volume: 54, Issue:3 Topics: Adult; Antiparkinson Agents; Humans; Levodopa; Male; Multiple System Atrophy; Parkinson Disease; Pergolide	2002
Sleep disorders and their determinants in multiple system atrophy. Journal of neurology, neurosurgery, and psychiatry, 2002, Volume: 72, Issue:6 Topics: Aged; Antiparkinson Agents; Depression; Female; Humans; Incidence; Levodopa; Male; Middle Aged; Multiple System Atrophy; Parkinson Disease; Severity of Illness Index; Sleep Wake Disorders	2002